Novavax Set For India Launch With Sii As Mfg Partner

Novavax Set For India Launch With Sii As Mfg Partner

By, Admin 16 June 2021

The Uncertain Path To Authorisation In The Us For Novavax Despite Passing The Efficacy Test With An Impressive Score Of 90.4% Might See India Emerge As A Major Hub For The Shots With The Serum Institute Of India As Manufacturing Partner.The Large Novavax Trials Conducted On 29,960 Persons In The Us And Mexico Have Delivered Results That Equal The Pfizer And Moderna Jabs And Do Better Than Johnson &Amp; Johnson, But Regulatory Clearance Appears Distant As An Overflowing Vault Of Vaccines Has Diminished The Need For Emergency Use Approvals. Under The Us Law, There Is No Need For Additional Euas Once There Are Enough Doses To Cater To Domestic Needs.&Lsquo;Sii Planning Covovax Trials For Kids&Rsquo;A Report In Nyt Quotes Novavax Chief Executive Stanley Erck Acknowledging That The First Approvals For The Vaccine Are Likely To Be Accorded Abroad And That The Company Has Applied In Uk, Eu, Korea And India. India Can Take A Cue From Uk Regulator But May Proceed Itself On Basis Of Strong Interim Data, Indian Sources Said. As Per Indian Government Estimates, 20 Crore Novavax Shots (Five Crore A Month) Can Be Available During September-December And Number May RiseNovavax, Named Covovax In India, Is In Advanced Stages Of Phase 2/3 &Ldquo;Observer-Blinded, Randomised, Active-Controlled&Rdquo; Bridging Trials With Sii Enrolling 1,600 Participants Over 18 Years Across 15 Centres. Sii Has Also Indicated An Interest In Conducting Trials In Children, Sources Said. It May Well Be Possible That India Becomes The First Country For Vaccine Launch.&Ldquo;The Results Are Very Encouraging And We&Rsquo;Re Looking Forward To The Vaccine. We Are Engaged With Sii For Supplies And The Company Is Doing Trials With Icmr. It Is A Very Promising Vaccine Candidate And We Are Hopeful That They Will Be Able To Submit Data In India For Regulatory Approvals Very Soon,&Rdquo; An Official Said.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!